Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371320020630030179
Journal of the Korean Surgical Society
2002 Volume.63 No. 3 p.179 ~ p.186
Evaluation of Resorbable Materials for Preventing Surgical Adhesion on Rat Experiment
Shim Hee-Soo

Lee Young-Woo
Oh Young-Ha
Kwon Sung-Won
Kim Jin-Hong
Sohn Seung-Kook
Abstract
Purpose: Postsurgical adhesion formation is still a cause of postoperative morbidity because no satisfactory treatment or prophylaxis has yet been developed. Therefore, we have established an animal model for adhesion prevention, and
evaluated
the toxicity, inflammation and adhesion prevention effect of available water soluble materials as barriers against adhesion formation.

Methods: Four-week old female Sprague-Dawley rats (Sam: TacN(SD)BR, Smatako Co., Seoul Korea) were used. The 2 §² of cecal serosa and adjacent abdominal wall were abraded with bone burr, and the serosa of the cecum was sutured to the
abdominal
wall 1 §¯ apart from the injured site. The denuded cecum was covered with either sodium hyaluronate (HA), sodium alginate (Alg), sodium carboxymethyl cellulose (CMC), polyethylene glycol-polypropylene glycol-polyethylene glycol (PEG-PPG,
Poloxamer), or
polyethylene glycol (PEG) on both sides, or neither side (control group) and apposed to the abdominal wall. Two weeks after operation, the quality of adhesion was graded using a whole-number system of zero to five.

Results: Adhesion grades were highest in the control group (average 4.8), were a little lower in the PEG-PPG (aver. 4.6) and PEG (aver. 4.1) groups, and were significantly lower in the HA (aver. 3.1), Alg (aver. 3.3) and CMC (aver. 3.0)
groups
(all, P£¼0.05). However but inflammation was revealed in the Alg and CMC groups.

Conclusion: In our animal model for adhesion prevention, a fairly good antiadhesion effect was attained with Alg, CMC and HA, whereas inflammation was revealed with Alg and CMC. In conclusion, HA is the best candidate for adhesion
prevention.
KEYWORD
FullTexts / Linksout information
   
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø